Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Sep 18, 2026, 4:00 PM EDT
1.330
+0.020 (1.53%)
After-hours: Sep 18, 2026, 7:47 PM EDT
Celularity Revenue
In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. Celularity had revenue of $4.10M in the quarter ending December 31, 2025, a decrease of -77.37%.
Revenue (ttm)
$26.55M
Revenue Growth
-51.03%
P/S Ratio
1.43
Revenue / Employee
$230,870
Employees
115
Market Cap
37.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.55M | -27.67M | -51.03% |
| Dec 31, 2024 | 54.22M | 31.45M | 138.11% |
| Dec 31, 2023 | 22.77M | 4.80M | 26.68% |
| Dec 31, 2022 | 17.98M | -3.36M | -15.75% |
| Dec 31, 2021 | 21.34M | 7.06M | 49.43% |
| Dec 31, 2020 | 14.28M | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Actinium Pharmaceuticals | 35.09M |
| Veru Inc. | 16.89M |
| Immutep | 13.79M |
| Metagenomi Therapeutics | 13.56M |
| Seres Therapeutics | 1.88M |
| CervoMed | 331.30K |
| aTyr Pharma | 190.00K |
CELU News
- 23 days ago - Why Is Penny Stock Celularity (CELU) Up 115% Today? - TipRanks
- 23 days ago - Celularity, MuseCell Innovations announce U.S. manufacturing collaboration - TheFly
- 23 days ago - Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform - Business Wire
- 25 days ago - Celularity provides updates regarding NASDAQ listing compliance - TheFly
- 25 days ago - Celularity Provides Update Regarding Nasdaq Listing Compliance - GlobeNewsWire
- 3 months ago - Penny Stocks: Why Is Celularity (CELU) Stock Trending Today? - TipRanks
- 3 months ago - Celularity announces cenplacel-L availability for investigational use in Florida - TheFly
- 3 months ago - Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies - GlobeNewsWire